Correction to “MEMS impedance flow cytometry designs for effective manipulation of micro entities in health care applications” [Biosens. Bioelectron], 2019, 142, 111526

Microfluidic flow cytometry for blood-based biomarker analysis

“…We will briefly summarise these techniques in the following sections, full details of them have been reviewed elsewhere. 95,[99][100][101] 3.1 Optical-based detecting systems Forward scatter (FSC) and side scatter (SSC) signals, as well as at least a few fluorescence colours signals, are always acquired by traditional flow cytometers. 102,103 The FSC and SSC data reveal sample size and internal granularity, whereas the fluorescent data allows immunophenotyping to be used to distinguish between distinct sample types.…”

Nanoflower-shaped MXene-based field-effect transistor capable of ultrasensitive microRNA-21 determination towards efficient lung cancer diagnosis

“…Compared to traditional strategies such as using electrochemistry, enzyme-linked immunosorbent assay (ELISA), and Raman spectroscopy, field-effect transistor (FET) biosensors offer high sensitivity by controlling the output circuit current through the manipulation of the input circuit's electric field, [4][5][6][7][8] relying on the semiconductor material's inherent sensitivity. [9][10][11][12] Therefore, the selection and optimization of semiconductor materials is paramount, depending on the semiconductor characteristics and morphology. MXene, a transition metal carbide, widely used in energy storage, capacitors, and biomedical applications, has been reported to possess superior semiconductor properties.…”

Viscoelastic Capillary Flow Cytometry

“…Even though it is the most favored method for commercial flow cytometry instruments, it suffers from the need to use multiple pumping channels for more than one inlet. Externally applied actuation forces such as electric, [41][42][43] magnetic, [44][45][46][47] and acoustic [48,49] forces have also been applied in MFC devices. However, such strategies require external sources, i.e., additional complexity.…”